Kinaxis Inc. (TSE:KXS – Get Free Report) Director Elizabeth (Betsy) Rafael sold 5,515 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of C$171.16, for a total value of C$943,941.33.
Kinaxis Trading Up 1.3 %
Shares of TSE:KXS opened at C$179.43 on Thursday. The company’s fifty day simple moving average is C$161.73 and its 200 day simple moving average is C$156.45. Kinaxis Inc. has a 12 month low of C$132.93 and a 12 month high of C$179.63. The firm has a market cap of C$5.07 billion, a price-to-earnings ratio of 175.60, a PEG ratio of 3.60 and a beta of 0.78. The company has a quick ratio of 2.29, a current ratio of 1.90 and a debt-to-equity ratio of 12.40.
Kinaxis (TSE:KXS – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported C$0.47 EPS for the quarter, beating the consensus estimate of C$0.43 by C$0.04. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%. The firm had revenue of C$165.79 million for the quarter, compared to analysts’ expectations of C$170.56 million. As a group, research analysts forecast that Kinaxis Inc. will post 4.2526231 EPS for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Research Report on KXS
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
See Also
- Five stocks we like better than Kinaxis
- Investing in Construction Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Capture the Benefits of Dividend Increases
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.